Skip to main content
Erschienen in: Diabetologia 2/2006

01.02.2006 | Article

Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins

verfasst von: Y. Jamshidi, H. Snieder, X. Wang, T. D. Spector, N. D. Carter, S. D. O’Dell

Erschienen in: Diabetologia | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Inhibition of signal transduction by suppressor of cytokine signalling-3 (SOCS-3) potentially influences resistance to insulin and leptin. The aim of this study was to test the association between three single-nucleotide polymorphisms (SNPs) representative of common linkage disequilibrium clusters in SOCS3 (rs4969169, rs12953258 and rs8064821) and obesity measures, insulin sensitivity measures and serum lipids in the general population.

Methods

The three SNPs, which had rare allele frequencies >0.06, were genotyped in 2,777 female twins of European extraction (mean age 47.4±12.5 years) from the St Thomas’ UK Adult Twin Registry (Twins UK).

Results

Minor allele frequencies were as follows: rs4969169=0.067, rs12953258=0.097 and rs8064821=0.101. Individual SOCS3 SNPs were not associated with general or central obesity, or with two indices of insulin sensitivity (homeostasis model assessment and insulin sensitivity measure).

Conclusions/interpretation

The results do not indicate that any of the three SNPs studied are associated with obesity, insulin measures or lipid measures.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387PubMedCrossRef Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19:378–387PubMedCrossRef
2.
Zurück zum Zitat Munzberg H, Myers MG (2005) Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:566–570PubMedCrossRef Munzberg H, Myers MG (2005) Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:566–570PubMedCrossRef
3.
Zurück zum Zitat Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170–184PubMedCrossRef Pirola L, Johnston AM, Van Obberghen E (2004) Modulation of insulin action. Diabetologia 47:170–184PubMedCrossRef
4.
Zurück zum Zitat Gylvin T, Nolsoe R, Hansen T et al (2004) Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity. Diabetologia 47:1273–1277PubMedCrossRef Gylvin T, Nolsoe R, Hansen T et al (2004) Mutation analysis of suppressor of cytokine signalling 3, a candidate gene in Type 1 diabetes and insulin sensitivity. Diabetologia 47:1273–1277PubMedCrossRef
5.
Zurück zum Zitat Spector TD, MacGregor AJ (2002) The St. Thomas’ UK Adult Twin Registry. Twin Res 5:440–443PubMedCrossRef Spector TD, MacGregor AJ (2002) The St. Thomas’ UK Adult Twin Registry. Twin Res 5:440–443PubMedCrossRef
6.
Zurück zum Zitat Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, MacGregor AJ. (2001) Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res 4:464–477PubMedCrossRef Andrew T, Hart DJ, Snieder H, de Lange M, Spector TD, MacGregor AJ. (2001) Are twins and singletons comparable? A study of disease-related and lifestyle characteristics in adult women. Twin Res 4:464–477PubMedCrossRef
7.
Zurück zum Zitat Middelberg RP, Spector TD, Swaminathan R, Snieder H (2002) Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 22:1142–1147PubMedCrossRef Middelberg RP, Spector TD, Swaminathan R, Snieder H (2002) Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 22:1142–1147PubMedCrossRef
8.
Zurück zum Zitat de Lange M, Snieder H, Ariens RA, Andrew T, Grant PJ, Spector TD (2003) The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. Twin Res 6:152–161PubMedCrossRef de Lange M, Snieder H, Ariens RA, Andrew T, Grant PJ, Spector TD (2003) The relation between insulin resistance and hemostasis: pleiotropic genes and common environment. Twin Res 6:152–161PubMedCrossRef
9.
Zurück zum Zitat Trégouët D-A, Ducimetère P, Tiret, L (1997) Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. Am J Hum Genet 61:189–199PubMedCrossRef Trégouët D-A, Ducimetère P, Tiret, L (1997) Testing association between candidate-gene markers and phenotype in related individuals, by use of estimating equations. Am J Hum Genet 61:189–199PubMedCrossRef
10.
Zurück zum Zitat Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L (1999) Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 23:512–517PubMedCrossRef Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L (1999) Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 23:512–517PubMedCrossRef
11.
Zurück zum Zitat Hanley AJ, Williams K, Gonzalez C, D’Agostino RB, Jr, Wagenknecht LE, Stern MP, Haffner SM (2003) Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463–469PubMedCrossRef Hanley AJ, Williams K, Gonzalez C, D’Agostino RB, Jr, Wagenknecht LE, Stern MP, Haffner SM (2003) Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 52:463–469PubMedCrossRef
12.
Zurück zum Zitat Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79–91PubMedCrossRef Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79–91PubMedCrossRef
13.
Zurück zum Zitat Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCrossRef Stephens M, Donnelly P (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169PubMedCrossRef
14.
Zurück zum Zitat Dong Y, Zhu H, Wang X, Dalageorgou C, Carter N, Spector TD, Snieder H (2004) Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics 14:419–427PubMedCrossRef Dong Y, Zhu H, Wang X, Dalageorgou C, Carter N, Spector TD, Snieder H (2004) Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics 14:419–427PubMedCrossRef
15.
Zurück zum Zitat Christensen K, Vaupel J, Holm NV, Yashin AI (1995) Twin mortality after age six: fetal origin hypothesis versus twin method. BMJ 310:432–436PubMed Christensen K, Vaupel J, Holm NV, Yashin AI (1995) Twin mortality after age six: fetal origin hypothesis versus twin method. BMJ 310:432–436PubMed
16.
Zurück zum Zitat Sham PC, Cherny SS, Purcell S, Hewitt JK (2000) Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet 66:1616–1630PubMedCrossRef Sham PC, Cherny SS, Purcell S, Hewitt JK (2000) Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet 66:1616–1630PubMedCrossRef
17.
Zurück zum Zitat Ueki K, Kondo T, Tseng YH, Kahn CR (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 101:10422–10427PubMedCrossRef Ueki K, Kondo T, Tseng YH, Kahn CR (2004) Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA 101:10422–10427PubMedCrossRef
Metadaten
Titel
Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins
verfasst von
Y. Jamshidi
H. Snieder
X. Wang
T. D. Spector
N. D. Carter
S. D. O’Dell
Publikationsdatum
01.02.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 2/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-0093-3

Weitere Artikel der Ausgabe 2/2006

Diabetologia 2/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.